Generex makes new appointment
This article was originally published in Scrip
Generex Biotechnology, a US company focused on drug delivery for metabolic diseases through the inner lining of the mouth, has appointed Stephen Fellows vice-president of finance. He was previously chief financial officer of Sona Mobile Holdings.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.